Page last updated: 2024-09-02

valerates and arginyl-glutamine

valerates has been researched along with arginyl-glutamine in 3 studies

Compound Research Comparison

Studies
(valerates)
Trials
(valerates)
Recent Studies (post-2010)
(valerates)
Studies
(arginyl-glutamine)
Trials
(arginyl-glutamine)
Recent Studies (post-2010) (arginyl-glutamine)
2,251294457625

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ichikawa, K; Imai, H; Matsuhashi, N; Nonaka, K; Okumura, N; Osada, S; Sasaki, Y; Takahashi, T; Tanahashi, T; Tanaka, Y; Yamaguchi, K; Yawata, K; Yoshida, K1
Asada, Y; Imai, T; Ishida, E; Katagiri, K; Matsuura, K; Sadayasu, R; Sagai, S; Saijo, S; Saito, D; Wada, H1
Hamauchi, S; Mori, K; Ogawa, H; Onitsuka, T; Onoe, T; Suzuki, M; Yamashita, A; Yokota, T; Yoshida, Y; Yurikusa, T1

Trials

2 trial(s) available for valerates and arginyl-glutamine

ArticleYear
Effect of HMB/Arg/Gln on the prevention of radiation dermatitis in head and neck cancer patients treated with concurrent chemoradiotherapy.
    Japanese journal of clinical oncology, 2014, Volume: 44, Issue:5

    Topics: Adult; Aged; Antineoplastic Agents; Chemoradiotherapy; Dietary Supplements; Dipeptides; Female; Head and Neck Neoplasms; Humans; Incidence; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiodermatitis; Radiotherapy Dosage; Severity of Illness Index; Treatment Outcome; Valerates

2014
A phase II study of HMB/Arg/Gln against oral mucositis induced by chemoradiotherapy for patients with head and neck cancer.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2018, Volume: 26, Issue:9

    Topics: Adult; Aged; Chemoradiotherapy; Dipeptides; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Quality of Life; Stomatitis; Valerates; Young Adult

2018

Other Studies

1 other study(ies) available for valerates and arginyl-glutamine

ArticleYear
A case report on efficacy of Aboundâ„¢ for anti-EGFR antibody-associated skin disorder in metastatic colon cancer.
    World journal of surgical oncology, 2014, Feb-11, Volume: 12

    Topics: Aged; Antibodies, Monoclonal; Colonic Neoplasms; Dipeptides; ErbB Receptors; Humans; Lung Neoplasms; Male; Panitumumab; Prognosis; Skin Diseases; Valerates

2014